Asia
Chong Kun Dang Pharmaceutical to Invest KRW392.5 Billion in Biopharmaceutical R&D Center
Chong Kun Dang Pharmaceutical (KRX:185750) plans to invest a total of 392.5 billion won to build a research and demonstration center for biopharmaceutical research and development in Baegot-dong, Siheung-si, according to a Tuesday filing with the Korea Exchange.The investment will be made from June 11, 2026, to Aug. 31, 2028.Shares of Chong Kun Dang Pharmaceutical rose more than 2% in recent trade.
KRX:185750
